Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LMNR
|
Mark Palamountain
SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 650 Reduced 1.02% |
$11,057
$17.01 p/Share
|
Jan 25
2021 |
|
LMNR
|
Harold S Edwards
President and CEO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.61% |
$17,010
$17.01 p/Share
|
Jan 25
2021 |
|
GOCO
|
Shane E. Cruz
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 75,000 Reduced 100.0% |
$1,098,000
$14.64 p/Share
|
Jan 25
2021 |
|
SMLR
|
Douglas Murphy Chutorian
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 100.0% |
$113,112
$90.49 p/Share
|
Jan 25
2021 |
|
EPZM
|
Robert B Bazemore
President & CEO |
SELL
Open market or private sale
|
Direct | 6,069 Reduced 2.39% |
$69,247
$11.41 p/Share
|
Jan 25
2021 |
|
EPZM
|
Matthew Ros
Officer |
SELL
Open market or private sale
|
Direct | 2,872 Reduced 4.88% |
$32,770
$11.41 p/Share
|
Jan 25
2021 |
|
EPZM
|
Victoria Vakiener
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 599 Reduced 2.1% |
$6,835
$11.41 p/Share
|
Jan 25
2021 |
|
EPZM
|
Shefali Agarwal |
SELL
Open market or private sale
|
Direct | 2,872 Reduced 3.65% |
$32,770
$11.41 p/Share
|
Jan 25
2021 |
|
VRA
|
P. Michael Miller |
SELL
Open market or private sale
|
Indirect | 71,503 Reduced 3.35% |
$609,206
$8.52 p/Share
|
Jan 25
2021 |
|
VRA
|
Patricia R. Miller |
SELL
Open market or private sale
|
Indirect | 71,503 Reduced 3.35% |
$609,206
$8.52 p/Share
|
Jan 25
2021 |
|
APRN
|
Matthew B Salzberg
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 13,700 Reduced 10.65% |
$137,822
$10.06 p/Share
|
Jan 25
2021 |
|
RDI
|
Margaret Cotter
Chairperson, EVP - RE Dev/NY |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.24% |
$29,680
$7.42 p/Share
|
Jan 25
2021 |
|
RDI
|
James J. Cotter Living Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 0.24% |
$29,680
$7.42 p/Share
|
Jan 25
2021 |
|
RDI
|
Ellen M Cotter
Director, President and CEO |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.24% |
$29,680
$7.42 p/Share
|
Jan 25
2021 |
|
MMNFF
|
Wicklow Capital Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 118,800 Reduced 0.61% |
$26,136
$0.22 p/Share
|
Jan 25
2021 |
|
AXDX
|
Steven Reichling
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 20,761 Reduced 60.95% |
$219,029
$10.55 p/Share
|
Jan 25
2021 |
|
KOSS
|
Lenore Lillie
VP - Operations |
SELL
Open market or private sale
|
Direct | 24,000 Reduced 54.44% |
$110,400
$4.6 p/Share
|
Jan 25
2021 |
|
KOSS
|
David Donnan Smith
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 24,000 Reduced 48.98% |
$140,400
$5.85 p/Share
|
Jan 25
2021 |
|
EMAN
|
Stillwater Holdings LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 894,001 Reduced 39.73% |
$2,583,663
$2.89 p/Share
|
Jan 25
2021 |
|
TYME
|
Michael Demurjian
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.08% |
$41,400
$2.07 p/Share
|
Jan 25
2021 |
|
DRNA
|
Bob D Brown
Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct | 21,630 Reduced 50.13% |
$540,750
$25.0 p/Share
|
Jan 25
2021 |
|
DRNA
|
Regina M. Paglia
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 6,326 Reduced 100.0% |
$158,150
$25.0 p/Share
|
Jan 25
2021 |
|
BDR
|
Cavalry Fund I LP
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 4.21% |
$74,000
$1.48 p/Share
|
Jan 25
2021 |
|
MCOA
|
Themistocles Psomiadis
Director |
SELL
Open market or private sale
|
Direct | 2,000,000 Reduced 16.66% |
$20,000
$0.01 p/Share
|
Jan 25
2021 |
|
FAST
|
Nicholas J Lundquist |
SELL
Open market or private sale
|
Indirect | 574 Reduced 100.0% |
$27,495
$47.9 p/Share
|
Jan 25
2021 |
|
CRTO
|
Ryan Damon
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 126 Reduced 0.19% |
$2,347
$18.63 p/Share
|
Jan 25
2021 |
|
EMED
|
Donald J Steinberg
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.51% |
$10,200
$0.51 p/Share
|
Jan 25
2021 |
|
ATAO
|
Erop Capital LLC |
SELL
Open market or private sale
|
Direct | 770,000 Reduced 1.73% |
$138,600
$0.18 p/Share
|
Jan 25
2021 |
|
SQ
|
Jack Dorsey
Block Head and Chairperson |
SELL
Open market or private sale
|
Indirect | 12,148 Reduced 100.0% |
$2,647,171
$217.91 p/Share
|
Jan 25
2021 |
|
AMTX
|
Andrew B Foster
Executive Vice President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 65.64% |
$75,500
$7.55 p/Share
|
Jan 25
2021 |
|
AMTX
|
Todd Waltz
Executive Vice President, CFO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 5.7% |
$71,100
$7.11 p/Share
|
Jan 25
2021 |
|
ICCH
|
Rock Island Investors, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,934 Reduced 1.26% |
$70,310
$14.25 p/Share
|
Jan 25
2021 |
|
MRNA
|
Stephen Hoge
President |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.31% |
$1,365,050
$273.01 p/Share
|
Jan 24
2021 |
|
GCMG
|
Adage Capital Partners Gp, L.L.C.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 11,588 Reduced 0.21% |
$155,511
$13.42 p/Share
|
Jan 22
2021 |
|
SLNO
|
Jack W Schuler |
SELL
Open market or private sale
|
Indirect | 72,591 Reduced 0.66% |
$151,715
$2.09 p/Share
|
Jan 22
2021 |
|
LOV
|
David Khalil
Director |
SELL
Open market or private sale
|
Indirect | 485 Reduced 0.03% |
$3,056
$6.3 p/Share
|
Jan 22
2021 |
|
CBDS
|
David Tobias
CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.31% |
$10,500
$1.05 p/Share
|
Jan 22
2021 |
|
BFST
|
Donald A. Hingle Ii
EVP & CCE of b1Bank |
SELL
Open market or private sale
|
Direct | 1,190 Reduced 8.72% |
$25,442
$21.38 p/Share
|
Jan 22
2021 |
|
MOTS
|
Perceptive Advisors LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 550,000 Reduced 17.13% |
$814,000
$1.48 p/Share
|
Jan 22
2021 |
|
PCVX
|
Robert Lorne Hopfner
Director |
SELL
Open market or private sale
|
Indirect | 11,383 Reduced 0.61% |
$286,396
$25.16 p/Share
|
Jan 22
2021 |
|
DIS
|
Robert A Iger
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,640 Reduced 1.31% |
$2,737,156
$175.01 p/Share
|
Jan 22
2021 |
|
HARP
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect | 24,695 Reduced 0.56% |
$536,375
$21.72 p/Share
|
Jan 22
2021 |
|
PFSI
|
Stanford L Kurland
Director |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.01% |
$59,450
$59.45 p/Share
|
Jan 22
2021 |
|
FATE
|
J Scott Wolchko
President and CEO |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 7.08% |
$2,962,800
$98.76 p/Share
|
Jan 22
2021 |
|
PACB
|
Michael Hunkapiller
Director |
SELL
Open market or private sale
|
Direct | 150,857 Reduced 15.1% |
$5,551,537
$36.8 p/Share
|
Jan 22
2021 |
|
RMNI
|
Daniel B. Winslow
EVP, CLO & Corp. Sec. |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 34.06% |
$72,300
$7.23 p/Share
|
Jan 22
2021 |
|
SLQT
|
William Thomas Grant Iii
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 8,300 Reduced 0.52% |
$207,666
$25.02 p/Share
|
Jan 22
2021 |
|
SLQT
|
William Thomas Grant Iii
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Indirect | 11,046 Reduced 0.6% |
$276,371
$25.02 p/Share
|
Jan 22
2021 |
|
SLQT
|
W Thomas Grant Ii
Director |
SELL
Open market or private sale
|
Direct | 8,300 Reduced 0.28% |
$207,666
$25.02 p/Share
|
Jan 22
2021 |
|
SLQT
|
W Thomas Grant Ii
Director |
SELL
Open market or private sale
|
Indirect | 8,279 Reduced 0.53% |
$207,141
$25.02 p/Share
|
Jan 22
2021 |